Inhaled and intranasal ciclesonide for the treatment of covid-19 in adult outpatients: CONTAIN phase II randomised controlled trial

OBJECTIVE: To determine if inhaled and intranasal ciclesonide are superior to placebo at decreasing respiratory symptoms in adult outpatients with covid-19. DESIGN: Randomised, double blind, placebo controlled trial. SETTING: Three Canadian provinces (Quebec, Ontario, and British Columbia). PARTICIP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ezer, Nicole, Belga, Sara, Daneman, Nick, Chan, Adrienne, Smith, Benjamin M, Daniels, Shay-Anne, Moran, Kristen, Besson, Charlotte, Smyth, Louisa Y, Bartlett, Susan J, Benedetti, Andrea, Martin, James G, Lee, Todd C, McDonald, Emily G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group Ltd. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561042/
https://www.ncbi.nlm.nih.gov/pubmed/34728476
http://dx.doi.org/10.1136/bmj-2021-068060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8561042/
https://www.ncbi.nlm.nih.gov/pubmed/34728476
http://dx.doi.org/10.1136/bmj-2021-068060

Ejemplares similares